UnitedHealth Group Incorporated (NYSE:UNH) is Lombard Odier Asset Management Switzerland SA’s 3rd Largest Position

Lombard Odier Asset Management Switzerland SA increased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 28.9% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 47,229 shares of the healthcare conglomerate’s stock after purchasing an additional 10,575 shares during the quarter. UnitedHealth Group makes up approximately 3.2% of Lombard Odier Asset Management Switzerland SA’s holdings, making the stock its 3rd largest holding. Lombard Odier Asset Management Switzerland SA’s holdings in UnitedHealth Group were worth $22,700,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. 25 LLC acquired a new stake in UnitedHealth Group in the 1st quarter worth about $28,000. Cascade Investment Advisors Inc. purchased a new stake in UnitedHealth Group during the first quarter worth approximately $28,000. Strategic Investment Solutions Inc. IL acquired a new stake in shares of UnitedHealth Group in the first quarter worth $35,000. Clear Investment Research LLC increased its position in shares of UnitedHealth Group by 216.7% in the first quarter. Clear Investment Research LLC now owns 76 shares of the healthcare conglomerate’s stock worth $36,000 after acquiring an additional 52 shares in the last quarter. Finally, WFA of San Diego LLC acquired a new stake in shares of UnitedHealth Group in the second quarter worth $39,000. Hedge funds and other institutional investors own 85.69% of the company’s stock.

UnitedHealth Group Price Performance

UnitedHealth Group stock traded down $2.03 during trading hours on Friday, hitting $550.94. 778,508 shares of the company traded hands, compared to its average volume of 3,278,305. The firm has a market cap of $509.58 billion, a P/E ratio of 24.00, a P/E/G ratio of 1.62 and a beta of 0.63. The company has a quick ratio of 0.80, a current ratio of 0.80 and a debt-to-equity ratio of 0.65. The firm’s 50-day simple moving average is $529.75 and its two-hundred day simple moving average is $501.63. UnitedHealth Group Incorporated has a 1-year low of $445.68 and a 1-year high of $554.70.

UnitedHealth Group (NYSE:UNH – Get Free Report) last announced its quarterly earnings data on Friday, October 13th. The healthcare conglomerate reported $6.56 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.33 by $0.23. The company had revenue of $92.36 billion for the quarter, compared to analysts’ expectations of $91.41 billion. UnitedHealth Group had a net margin of 6.02% and a return on equity of 26.58%. The business’s revenue was up 14.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $5.79 EPS. As a group, analysts forecast that UnitedHealth Group Incorporated will post 24.94 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 12th. Stockholders of record on Monday, December 4th will be given a dividend of $1.88 per share. The ex-dividend date is Friday, December 1st. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.36%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 32.64%.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on the stock. StockNews.com lowered shares of UnitedHealth Group from a “strong-buy” rating to a “buy” rating in a research report on Saturday, October 21st. Truist Financial reiterated a “buy” rating and set a $610.00 price objective on shares of UnitedHealth Group in a research note on Thursday. Piper Sandler increased their price objective on shares of UnitedHealth Group from $580.00 to $584.00 and gave the company an “overweight” rating in a research note on Monday, October 16th. Cantor Fitzgerald reiterated an “overweight” rating and set a $591.00 price objective on shares of UnitedHealth Group in a research note on Tuesday, November 21st. Finally, Stephens reiterated an “overweight” rating and set a $585.00 price objective on shares of UnitedHealth Group in a research note on Thursday. Two research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and a consensus price target of $579.65.

Check Out Our Latest Analysis on UnitedHealth Group

Insider Activity

In other news, EVP Erin Mcsweeney sold 4,498 shares of the stock in a transaction on Monday, October 16th. The stock was sold at an average price of $544.28, for a total value of $2,448,171.44. Following the completion of the sale, the executive vice president now owns 9,218 shares in the company, valued at $5,017,173.04. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, Director Stephen J. Hemsley sold 121,515 shares of the company’s stock in a transaction on Tuesday, October 17th. The shares were sold at an average price of $540.58, for a total value of $65,688,578.70. Following the transaction, the director now directly owns 521,818 shares of the company’s stock, valued at $282,084,374.44. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Erin Mcsweeney sold 4,498 shares of the company’s stock in a transaction on Monday, October 16th. The stock was sold at an average price of $544.28, for a total transaction of $2,448,171.44. Following the completion of the transaction, the executive vice president now directly owns 9,218 shares in the company, valued at $5,017,173.04. The disclosure for this sale can be found here. Insiders own 0.35% of the company’s stock.

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children’s health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Further Reading

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Before you consider UnitedHealth Group, you’ll want to hear this.

MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and UnitedHealth Group wasn’t on the list.

While UnitedHealth Group currently has a “Moderate Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here